Alton B Farris1, Robert B Colvin. 1. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia 30322, USA. abfarri@emory.edu
Abstract
PURPOSE OF REVIEW: Tubulointerstitial injury in the kidney is complex, involving a number of independent and overlapping cellular and molecular pathways, with renal interstitial fibrosis and tubular atrophy (IFTA) as the final common pathway. Furthermore, there are multiple ways to assess IFTA. RECENT FINDINGS: Cells involved include tubular epithelial cells, fibroblasts, fibrocytes, myofibroblasts, monocyte/macrophages, and mast cells with complex and still incompletely characterized cell-molecular interactions. Molecular mediators involved are numerous and involve pathways such as transforming growth factor (TGF)-β, bone morphogenic protein (BMP), platelet-derived growth factor (PDGF), and hepatocyte growth factor (HGF). Recent genomic approaches have shed insight into some of these cellular and molecular pathways. Pathologic evaluation of IFTA is central in assessing the severity of chronic disease; however, there are a variety of methods used to assess IFTA. Most assessment of IFTA relies on pathologist assessment of special stains such as trichrome, Sirius Red, and collagen III immunohistochemistry. Visual pathologist assessment can be prone to intra and interobserver variability, but some methods employ computerized morphometery, without a clear consensus as to the best method. SUMMARY: IFTA results from on orchestration of cell types and molecular pathways. Opinions vary on the optimal qualitative and quantitative assessment of IFTA.
PURPOSE OF REVIEW: Tubulointerstitial injury in the kidney is complex, involving a number of independent and overlapping cellular and molecular pathways, with renal interstitial fibrosis and tubular atrophy (IFTA) as the final common pathway. Furthermore, there are multiple ways to assess IFTA. RECENT FINDINGS: Cells involved include tubular epithelial cells, fibroblasts, fibrocytes, myofibroblasts, monocyte/macrophages, and mast cells with complex and still incompletely characterized cell-molecular interactions. Molecular mediators involved are numerous and involve pathways such as transforming growth factor (TGF)-β, bone morphogenic protein (BMP), platelet-derived growth factor (PDGF), and hepatocyte growth factor (HGF). Recent genomic approaches have shed insight into some of these cellular and molecular pathways. Pathologic evaluation of IFTA is central in assessing the severity of chronic disease; however, there are a variety of methods used to assess IFTA. Most assessment of IFTA relies on pathologist assessment of special stains such as trichrome, Sirius Red, and collagen III immunohistochemistry. Visual pathologist assessment can be prone to intra and interobserver variability, but some methods employ computerized morphometery, without a clear consensus as to the best method. SUMMARY:IFTA results from on orchestration of cell types and molecular pathways. Opinions vary on the optimal qualitative and quantitative assessment of IFTA.
Authors: Floortje M E G Steegh; Marielle A C J Gelens; Fred H M Nieman; Johannes P van Hooff; Jack P M Cleutjens; Robert Jan van Suylen; Mat J A P Daemen; Ernst L W van Heurn; Maarten H L Christiaans; Carine J Peutz-Kootstra Journal: J Am Soc Nephrol Date: 2011-05-12 Impact factor: 10.121
Authors: B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi Journal: Am J Transplant Date: 2010-01-29 Impact factor: 8.086
Authors: Neil C Henderson; Alison C Mackinnon; Sarah L Farnworth; Tiina Kipari; Christopher Haslett; John P Iredale; Fu-Tong Liu; Jeremy Hughes; Tariq Sethi Journal: Am J Pathol Date: 2008-01-17 Impact factor: 4.307
Authors: Lars Pape; Thomas Henne; Gisela Offner; Juergen Strehlau; Jochen H H Ehrich; Michael Mengel; Paul C Grimm Journal: Transplantation Date: 2003-09-27 Impact factor: 4.939
Authors: Feng Wang; Daisuke Katagiri; Ke Li; Keiko Takahashi; Suwan Wang; Shinya Nagasaka; Hua Li; C Chad Quarles; Ming-Zhi Zhang; Akira Shimizu; John C Gore; Raymond C Harris; Takamune Takahashi Journal: Magn Reson Med Date: 2018-05-30 Impact factor: 4.668
Authors: Jagdeesan Muralidharan; Ali Ramezani; Monica Hubal; Susan Knoblach; Shashi Shrivastav; Sara Karandish; Richard Scott; Nirmal Maxwell; Savas Ozturk; Srinivasan Beddhu; Jeffrey B Kopp; Dominic S Raj Journal: Am J Physiol Renal Physiol Date: 2017-01-11
Authors: Stephen Zewinger; Thomas Rauen; Michael Rudnicki; Giuseppina Federico; Martina Wagner; Sarah Triem; Stefan J Schunk; Ioannis Petrakis; David Schmit; Stefan Wagenpfeil; Gunnar H Heine; Gert Mayer; Jürgen Floege; Danilo Fliser; Hermann-Josef Gröne; Thimoteus Speer Journal: J Am Soc Nephrol Date: 2018-10-02 Impact factor: 10.121